BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20581794)

  • 1. Ziprasidone induced tardive cervical dystonia.
    Kutlu A; Dündar S; Altun NS; Budak F
    Psychopharmacol Bull; 2009; 42(4):64-8. PubMed ID: 20581794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dystonia associated with ziprasidone.
    Papapetropoulos S; Wheeler S; Singer C
    Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868
    [No Abstract]   [Full Text] [Related]  

  • 3. Tardive dyskinesia and ziprasidone.
    Rosenquist KJ; Walker SS; Ghaemi SN
    Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziprasidone-induced tardive dyskinesia.
    Mendhekar DN
    Can J Psychiatry; 2005 Aug; 50(9):567-8. PubMed ID: 16262114
    [No Abstract]   [Full Text] [Related]  

  • 6. Ziprasidone-induced galactorrhea: a case report.
    Kopecek M; Bares M; Mohr P
    Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia in a patient treated with quetiapine.
    Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
    World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia in 2 patients treated with ziprasidone.
    Ananth J; Burgoyne KS; Niz D; Smith M
    J Psychiatry Neurosci; 2004 Nov; 29(6):467-9. PubMed ID: 15644988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
    Hennings JM; Krause E; Bötzel K; Wetter TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziprasidone-related oculogyric crisis in an adult.
    Viana Bde M; Prais HA; Camargos ST; Cardoso FE
    Clin Neurol Neurosurg; 2009 Dec; 111(10):883-5. PubMed ID: 19717224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.
    Weinstein SK; Adler CM; Strakowski SM
    J Clin Psychiatry; 2006 Feb; 67(2):327-8. PubMed ID: 16566635
    [No Abstract]   [Full Text] [Related]  

  • 12. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 13. Ziprasidone-related tardive dyskinesia.
    Keck ME; Müller MB; Binder EB; Sonntag A; Holsboer F
    Am J Psychiatry; 2004 Jan; 161(1):175-6. PubMed ID: 14702272
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report.
    Rizos EN; Chatziioannou S; Siafakas N; Douzenis A; Katsantoni E; Mandrapilia A; Bacalis S; Fotiadis C; Lykouras L
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1135-6. PubMed ID: 20460141
    [No Abstract]   [Full Text] [Related]  

  • 15. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ; Girgis RR; Gil R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziprasidone-induced oculogyric crisis.
    Ramos AE; Shytle RD; Silver AA; Sanberg PR
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1013-4. PubMed ID: 12964566
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute dystonia after initial doses of ziprasidone: a case report.
    Yumru M; Savas HA; Selek S; Savas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):745-7. PubMed ID: 16580766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio.
    Espay AJ; Vaughan JE; Shukla R; Gartner M; Sahay A; Revilla FJ; Duker AP
    Mov Disord; 2011 Apr; 26(5):913-4. PubMed ID: 21432906
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
    Mellacheruvu S; Norton JW; Schweinfurth J
    J Clin Psychopharmacol; 2007 Apr; 27(2):206-7. PubMed ID: 17414248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.